Product image of Kaliumchlorid Braun (Potassium Chloride) supplied by GNH India

Kaliumchlorid Braun

Active Ingredient:
Potassium Chloride
Origin:
EU

Kaliumchlorid Braun (Potassium Chloride)

Potassium chloride, the active ingredient in Kaliumchlorid Braun, is an electrolyte (potassium salt) presented as an intravenous solution for intravenous use. It treats hypokalemia and provides potassium replacement therapy in patients who need rapid correction of low serum potassium levels.

GNH India supplies Kaliumchlorid Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Manufacturer / TM Owner

B.Braun Melsungen Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Kaliumchlorid Braun is used to correct potassium deficits and support electrolyte balance in several clinical situations.

  • Hypokalemia: restores serum potassium to normal concentrations.
  • Cardiac arrhythmia prevention: maintains adequate potassium to support normal cardiac electrophysiology.
  • Post‑operative care: replaces potassium lost during surgery or anesthesia.
  • Renal dialysis patients: replenishes potassium removed during dialysis sessions.

How It Works

  • Potassium chloride dissociates after intravenous administration, releasing potassium ions (K+) into the extracellular fluid. The increase in extracellular potassium raises serum potassium concentration, helping to re‑establish the normal electrochemical gradient across cell membranes. This restores membrane potential, improves neuromuscular function, and stabilises cardiac conduction, thereby correcting hypokalemia.

Side Effects

Potassium chloride injection may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Injection site pain: discomfort at the infusion site.
  • Phlebitis: inflammation of the vein used for administration.
  • Hyperkalemia (if over‑infused): elevated serum potassium levels.
  • Nausea: feeling of sickness.
  • Vomiting: expulsion of stomach contents.
  • Metallic taste: transient taste disturbance.

Serious or Rare Side Effects

  • Cardiac arrest due to severe hyperkalemia.
  • Anaphylactic reaction: severe allergic response.
  • Life‑threatening arrhythmias: ventricular fibrillation or asystole.
  • Pulmonary edema: fluid accumulation in the lungs.
  • Severe hypotension: sudden drop in blood pressure.

Precautions & Warnings

When using Kaliumchlorid Braun, clinicians should observe several safety measures.

  • Renal impairment: monitor serum potassium closely and adjust infusion rate.
  • Cardiac disease: use with caution; rapid shifts in potassium can affect heart rhythm.
  • Concomitant potassium‑sparing diuretics: increased risk of hyperkalemia.
  • Rapid infusion: may cause sudden hyperkalemia; infuse at recommended rates.
  • Pregnancy: safety not established; weigh potential benefits against risks.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Potassium chloride can interact with other medicines that influence potassium balance.

Major Interactions (Avoid)

  • ACE inhibitors: may precipitate dangerous hyperkalemia.
  • Potassium‑sparing diuretics (e.g., spironolactone): risk of severe hyperkalemia.
  • NSAIDs: can reduce renal potassium excretion, increasing serum levels.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: may affect potassium homeostasis.
  • Digoxin: elevated potassium can enhance digoxin toxicity.
  • Insulin therapy: insulin drives potassium into cells, potentially requiring dose adjustment.

Frequently Asked Questions

Kaliumchlorid Braun is an intravenous potassium chloride solution used to treat hypokalemia and to provide rapid potassium replacement in patients who need their serum potassium levels restored, such as after surgery, during dialysis, or when potassium‑depleting medications have been administered.

After infusion, potassium chloride dissociates into potassium and chloride ions. The potassium ions increase extracellular potassium concentration, helping to re‑establish the normal membrane potential of cells, support muscle and nerve function, and stabilise cardiac electrical activity, thereby correcting low serum potassium levels.

The dose of Kaliumchlorid Braun is determined by the prescribing clinician based on the patient’s serum potassium level, weight, renal function, and clinical condition. The healthcare professional calculates the appropriate infusion rate and total amount required for safe correction.

The safety of Kaliumchlorid Braun in pregnancy and lactation has not been fully established. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Kaliumchlorid Braun is an intravenous formulation, offering rapid correction of potassium deficits, whereas oral potassium salts (e.g., potassium gluconate tablets) provide slower, more gradual replenishment. IV delivery is preferred in acute settings, severe hypokalemia, or when oral intake is not feasible.

The solution should be stored at 2‑8 °C, protected from light, and must not be frozen or shaken. Keep the container in its original packaging until use, and discard any product that appears discoloured or contains particles.

Kaliumchlorid Braun is administered intravenously by a qualified healthcare professional. It is typically infused slowly through a peripheral or central line, following the infusion rate prescribed to avoid rapid shifts in serum potassium that could cause cardiac complications.

The most serious risks include severe hyperkalemia leading to cardiac arrhythmias, cardiac arrest, or sudden death. Anaphylactic reactions and severe hypotension can also occur, especially if the infusion is given too rapidly or in patients with compromised renal function.

Patients with known hypersensitivity to potassium chloride, those with severe hyperkalemia, untreated severe renal failure, or conditions where potassium accumulation is dangerous should not receive this product. Clinicians must evaluate each case individually before prescribing.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Potassium Chloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT